Log In
BCIQ
Print this Print this
 

HMBD-002

  Manage Alerts
Collapse Summary General Information
Company Hummingbird Bioscience Pte. Ltd.
Description 
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentDiscovery
Standard IndicationLiver cancer
Indication DetailsTreat hepatocellular carcinoma (HCC)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today